Literature DB >> 12737639

Use of complementary and alternative medicine by HIV-infected outpatients in Ontario, Canada.

Michelle D Furler1, Thomas R Einarson, Sharon Walmsley, Margaret Millson, Reina Bendayan.   

Abstract

Little is known about complementary and alternative medicine (CAM) use in Canadian patients with HIV. We sought to determine the prevalence of CAM use by patients attending HIV outpatient clinics in Ontario, Canada, and to compare the characteristics of users and nonusers. Impact of CAM definition on reported utilization rates was also assessed, specifically in relation to the inclusion and exclusion of vitamins, minerals, and multivitamins in CAM definition. In-person interviews were conducted between 1999 and 2001 with 104 HIV-positive outpatients enrolled in the HIV Ontario Observational Database project (HOOD) and attending HIV outpatient clinics in Ontario. Self-reported CAM utilization and demographic data were collected. Clinical data were obtained from medical chart review. Seventy-seven percent of participants reported current CAM use. Inclusion of vitamins and minerals (CAMVIT) increased this estimate to 89%. Nearly all patients used CAM in conjunction with antiretroviral medications. Out of pocket costs ranged from CAD$0 to more than CAD$250 per month. Most patients reported CAM use was beneficial and had improved their overall health. Female gender, HIV risk group, number of prescriptions, and overall number of drugs used were associated with CAM use. CAM use in Canadian patients with HIV is extremely common, with higher use among women. The definition of CAM has a substantial impact both on reported prevalence rates and on predictors of CAM use.

Entities:  

Mesh:

Year:  2003        PMID: 12737639     DOI: 10.1089/108729103321619764

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  24 in total

1.  Development and evaluation of a complementary and alternative medicine use survey in African-Americans with acquired immune deficiency syndrome.

Authors:  Ashli Owen-Smith; Claire Sterk; Frances McCarty; Dana Hankerson-Dyson; Ralph Diclemente
Journal:  J Altern Complement Med       Date:  2010-05       Impact factor: 2.579

Review 2.  A review of the use of complementary and alternative medicine and HIV: issues for patient care.

Authors:  Ava Lorenc; Nicola Robinson
Journal:  AIDS Patient Care STDS       Date:  2013-09       Impact factor: 5.078

Review 3.  Complementary and alternative medicine use among HIV-positive people: research synthesis and implications for HIV care.

Authors:  Rae A Littlewood; Peter A Vanable
Journal:  AIDS Care       Date:  2008-09

Review 4.  A global perspective on complementary and alternative medicine use among people living with HIV/AIDS in the era of antiretroviral treatment.

Authors:  Rae A Littlewood; Peter A Vanable
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

Review 5.  The assessment of complementary and alternative medicine use among individuals with HIV: a systematic review and recommendations for future research.

Authors:  Ashli Owen-Smith; Lara DePadilla; Ralph DiClemente
Journal:  J Altern Complement Med       Date:  2011-09       Impact factor: 2.579

6.  Knowledge, beliefs, and health care practices relating to treatment of HIV in Vellore, India.

Authors:  Anne Marie Belz Chomat; Ira B Wilson; Christine A Wanke; A Selvakumar; K R John; Rita Isaac
Journal:  AIDS Patient Care STDS       Date:  2009-06       Impact factor: 5.078

7.  Use of complementary and alternative medicine in inner-city persons with or at risk for HIV infection.

Authors:  Felise B Milan; Julia H Arnsten; Robert S Klein; Ellie E Schoenbaum; Galina Moskaleva; Donna Buono; Mayris P Webber
Journal:  AIDS Patient Care STDS       Date:  2008-10       Impact factor: 5.078

8.  Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women.

Authors:  Chenglong Liu; Yang Yang; Stephen J Gange; Kathleen Weber; Gerald B Sharp; Tracey E Wilson; Alexandra Levine; Esther Robison; Lakshmi Goparaju; Monica Gandhi; Monica Ganhdi; Dan Merenstein
Journal:  AIDS Patient Care STDS       Date:  2009-11       Impact factor: 5.078

9.  Rhabdomyolysis: a case study exploring the possible side effect of lipid lowering medication by a HIV positive patient taking a protease inhibitor.

Authors:  Diana De Carvalho; Mark Citro; Anthony Tibbles
Journal:  J Can Chiropr Assoc       Date:  2008-12

10.  MRN-100, an Iron-based Compound, Possesses Anti-HIV Activity In Vitro.

Authors:  Mamdooh Ghoneum; Magda Shaheen
Journal:  Evid Based Complement Alternat Med       Date:  2008-03-20       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.